Ribtype DSR Capsule is a combination medication containing Rabeprazole (20mg) and Domperidone (30mg), formulated to manage acid reflux, gastroesophageal reflux disease (GERD), gastritis, and related digestive disorders. It provides effective relief from acidity, bloating, nausea, and acid regurgitation by reducing stomach acid production and improving gastrointestinal motility.
Rabeprazole is a proton pump inhibitor (PPI) that works by blocking the acid-producing enzymes in the stomach, thereby reducing acid secretion and preventing conditions such as heartburn, peptic ulcers, and erosive esophagitis. Domperidone, a prokinetic agent, enhances stomach movement, facilitating faster gastric emptying and reducing symptoms of nausea, vomiting, and bloating.
This dual-action formula ensures long-lasting relief from acid-related disorders and helps restore digestive balance. It is beneficial for individuals suffering from chronic acid reflux, dyspepsia, and delayed gastric emptying. The combination is especially useful for those experiencing acid belching, discomfort after meals, or persistent acidity despite dietary changes.
Ribtype DSR Capsule is generally well-tolerated and is recommended for daily use under medical supervision. It is effective in preventing stomach ulcers caused by excessive acid production and provides prolonged relief from digestive discomfort. The formulation also helps patients suffering from acid regurgitation, gastritis, and nausea caused by excessive acid secretion.
It is best taken before meals for optimal efficacy, allowing better acid control throughout the day. Regular use under medical guidance can help prevent acid-induced damage to the stomach lining and improve overall gastric health.